Jeny Shklover

Technion – Israel Institute of Technology

Papers

2

Total Citations

114

H-Index

2

About

Dr. Jeny Shklover is a pioneering researcher at the intersection of robotics, microfluidics, nanotechnology, and artificial intelligence, with a primary focus on advancing drug delivery and synthetic biology. Her most impactful work, a 2021 paper with 112 citations, revolutionized the synthesis and evaluation of liposomes and polymeric drug delivery systems by integrating automation and AI, dramatically improving reproducibility and scalability. Building on this foundation, her 2025 study on scaling up synthetic cell production using robotics and machine learning marks a breakthrough in bottom-up synthetic biology. This work addresses a critical bottleneck—the manual, labor-intensive nature of synthetic cell synthesis—by introducing automated platforms that enable high-throughput production and characterization. Dr. Shklover’s contributions are pivotal for therapeutic applications, particularly in developing synthetic cells that can replace malfunctioning natural cells and treat diseases with precise spatiotemporal control. Her innovative fusion of engineering disciplines with biology positions her as a leader in the next generation of smart, automated biomedical tools, with the potential to transform personalized medicine and drug delivery.

Research Focus

Key Achievements

2
H-Index
2
Papers
114
Total Citations
57
Avg Citations/Paper
🏆 Most Cited Paper
Robotics, microfluidics, nanotechnology and AI in the synthesis and evaluation of liposomes and polymeric drug delivery systems
112 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Technion – Israel Institute of Technology

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago